The store will not work correctly when cookies are disabled.
2-acetyl-3-amino-4-(4-methoxyphenyl)-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-b]pyridin-6-one
ID: ALA5186334
Chembl Id: CHEMBL5186334
PubChem CID: 168282247
Max Phase: Preclinical
Molecular Formula: C15H16N4O3
Molecular Weight: 300.32
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(C2CC(=O)Nc3nn(C(C)=O)c(N)c32)cc1
Standard InChI: InChI=1S/C15H16N4O3/c1-8(20)19-14(16)13-11(7-12(21)17-15(13)18-19)9-3-5-10(22-2)6-4-9/h3-6,11H,7,16H2,1-2H3,(H,17,18,21)
Standard InChI Key: XMDJGTNKBJTPPW-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 300.32 | Molecular Weight (Monoisotopic): 300.1222 | AlogP: 1.61 | #Rotatable Bonds: 2 |
Polar Surface Area: 99.24 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.14 | CX Basic pKa: ┄ | CX LogP: 0.91 | CX LogD: 0.91 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.88 | Np Likeness Score: -0.52 |
References
1. Bou-Petit E, Hümmer S, Alarcon H, Slobodnyuk K, Cano-Galietero M, Fuentes P, Guijarro PJ, Muñoz MJ, Suarez-Cabrera L, Santamaria A, Estrada-Tejedor R, Borrell JI, Ramón Y Cajal S.. (2022) Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor., 65 (8.0): [PMID:35417652] [10.1021/acs.jmedchem.1c01941] |